Balchem Corp.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: US0576652004
USD
153.35
-0.75 (-0.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Balchem Corp. stock-summary
stock-summary
Balchem Corp.
FMCG
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, providing solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems. The Animal Nutrition & Health segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry. The Industrial Products segment includes the manufacture and sale of methylamines.
Company Coordinates stock-summary
Company Details
52 Sunrise Park Rd , NEW HAMPTON NY : 10958-4703
stock-summary
Tel: 1 845 3265600
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 87 Schemes (48.37%)

Foreign Institutions

Held by 131 Foreign Institutions (11.67%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Theodore Harris
Chairman of the Board, President, Chief Executive Officer
Dr. John Televantos
Lead Independent Director
Mr. Paul Coombs
Independent Director
Mr. David Fischer
Independent Director
Mr. Daniel Knutson
Independent Director
Ms. Joyce Lee
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
255 Million
(Quarterly Results - Jun 2025)
Net Profit:
38 Million
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 5,276 Million (Small Cap)

stock-summary
P/E

40.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

45.57%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

11.31%

stock-summary
Price to Book

4.16